Correspondence 0001493152-25-002404 from Hepion Pharmaceuticals, Inc. (HEPA)

Hepion Pharmaceuticals, Inc.
Date: Jan. 15, 2025 · CIK: 0001583771 · Accession: 0001493152-25-002404

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 333-284052

Date

Jan. 15, 2025

Author

Director

Form

CORRESP

Company

Hepion Pharmaceuticals, Inc.

Letter

Laidlaw & Company (UK) Ltd.

5th Ave,

New York, NY 10175

January 15, 2025

VIA EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

F Street, N.E.

Washington, D.C. 20549

Re: Hepion Pharmaceuticals, Inc. (the “Company”)

Registration Statement on Form S-1, as amended

File No: 333-284052 (the “Registration Statement”)

Ladies and Gentlemen:

Reference is made to our letter, filed as correspondence via EDGAR on January 14, 2025, in which Laidlaw & Company (UK) Ltd., as the Placement Agent, joined the Company’s request for acceleration of the effective date of the above-referenced Registration Statement for 5:00 pm Eastern Time on January 15, 2025, or as soon thereafter as practicable, in accordance with Rule 461 under the Securities Act of 1933, as amended. The Company is no longer requesting that such Registration Statement be declared effective at this time and we hereby formally withdraw our request for acceleration of the effective date.

Very
truly yours,
Laidlaw
& Company (UK) Ltd.

Show Raw Text

CORRESP
1
filename1.htm

Laidlaw
& Company (UK) Ltd.

521
5th Ave,

New
York, NY 10175

January
15, 2025

VIA
EDGAR

U.S.
Securities and Exchange Commission

Division
of Corporation Finance

100
F Street, N.E.

Washington,
D.C. 20549

    Re:
    Hepion
    Pharmaceuticals, Inc. (the “Company”)

    Registration
    Statement on Form S-1, as amended

    File
    No: 333-284052 (the “Registration Statement”)

Ladies
and Gentlemen:

Reference
is made to our letter, filed as correspondence via EDGAR on January 14, 2025, in which Laidlaw & Company (UK) Ltd., as the Placement
Agent, joined the Company’s request for acceleration of the effective date of the above-referenced Registration Statement for 5:00
pm Eastern Time on January 15, 2025, or as soon thereafter as practicable, in accordance with Rule 461 under the Securities Act of 1933,
as amended. The Company is no longer requesting that such Registration Statement be declared effective at this time and we hereby formally
withdraw our request for acceleration of the effective date.

    Very
    truly yours,

    Laidlaw
    & Company (UK) Ltd.

    By:
    /s/
    Hugh Regan

    Name:
    Hugh
Regan

    Title:
    Executive
    Director

SecProbe.io